Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
Heart drug tested to fight deadly blood infections
Disease control Not yet recruitingThis study is testing whether adding a short course of the blood-thinning drug clopidogrel to standard antibiotic treatment helps hospitalized patients with serious Staphylococcus aureus blood infections. About 230 patients will be randomly assigned to receive either the antibiot…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Apr 02, 2026 04:56 UTC
-
New hope for stubborn depression in seniors: nasal spray vs. pill in major trial
Disease control Not yet recruitingThis study aims to see if a nasal spray (esketamine) or a pill (aripiprazole) works better for older adults whose depression hasn't improved with standard antidepressants. It will involve 220 people aged 60-74 who have tried at least three different antidepressant treatments with…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists hunt for early warning signs of deadly infections in vulnerable cancer patients
Knowledge-focused Not yet recruitingThis study aims to understand and predict dangerous bacterial infections in cancer patients with very low white blood cell counts. Researchers will track over 500 patients with blood cancers to identify who is most at risk and develop a prediction tool. The goal is to help doctor…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC